Notably, FSCN1 is upregulated by TGFβ/Nodal signaling also in a range of tumor cells and overexpressed in different carcinomas where correlates with the clinical aggressiveness [139], suggesting that FSCN1 sustains TGFβ signaling also during tumor progression. The gene discussed is FSCN1; the disease is neoplasm.